全文获取类型
收费全文 | 1286篇 |
免费 | 60篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 116篇 |
妇产科学 | 13篇 |
基础医学 | 134篇 |
口腔科学 | 21篇 |
临床医学 | 144篇 |
内科学 | 286篇 |
皮肤病学 | 51篇 |
神经病学 | 34篇 |
特种医学 | 310篇 |
外科学 | 106篇 |
综合类 | 27篇 |
预防医学 | 39篇 |
眼科学 | 5篇 |
药学 | 55篇 |
中国医学 | 2篇 |
肿瘤学 | 59篇 |
出版年
2023年 | 5篇 |
2021年 | 7篇 |
2020年 | 9篇 |
2019年 | 8篇 |
2018年 | 17篇 |
2017年 | 3篇 |
2016年 | 7篇 |
2015年 | 14篇 |
2014年 | 14篇 |
2013年 | 42篇 |
2012年 | 31篇 |
2011年 | 27篇 |
2010年 | 36篇 |
2009年 | 56篇 |
2008年 | 23篇 |
2007年 | 64篇 |
2006年 | 30篇 |
2005年 | 30篇 |
2004年 | 28篇 |
2003年 | 37篇 |
2002年 | 28篇 |
2001年 | 14篇 |
2000年 | 18篇 |
1999年 | 21篇 |
1998年 | 71篇 |
1997年 | 79篇 |
1996年 | 101篇 |
1995年 | 61篇 |
1994年 | 59篇 |
1993年 | 52篇 |
1992年 | 19篇 |
1991年 | 15篇 |
1990年 | 23篇 |
1989年 | 39篇 |
1988年 | 38篇 |
1987年 | 35篇 |
1986年 | 48篇 |
1985年 | 44篇 |
1984年 | 14篇 |
1983年 | 17篇 |
1982年 | 14篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 11篇 |
1978年 | 12篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1975年 | 15篇 |
1974年 | 5篇 |
1973年 | 6篇 |
排序方式: 共有1403条查询结果,搜索用时 31 毫秒
11.
al-Shahi R; Mason JC; Rao R; Hurd C; Thompson EM; Haskard DO; Davies KA 《Rheumatology (Oxford, England)》1997,36(7):794-798
Thrombocytopenia in patients with acute systemic lupus erythematosus (SLE)
frequently presents the clinician with considerable diagnostic and
therapeutic difficulties. In this Grand Round, we present a 48-yr- old
woman with a 7 yr history of lupus, who presented with acute proliferative
glomerulonephritis and nephrotic syndrome, pneumonia, profound
hypocomplementaemia and a severe microangiopathic haemolytic anaemia with
associated thrombocytopenia. Her thrombocytopenia proved initially
refractory to conventional immunosuppressive therapy, and corticosteroids,
and resolved only with plasma exchange and repeated fresh frozen plasma
infusions. Serological testing revealed high-titre antinuclear antibodies
(ANA) and markedly raised antibodies to double- stranded (ds) DNA, but no
significant elevation in anticardiolipin antibodies. Platelet-associated
IgG and IgM and antibodies to the CD36 glycoprotein antigen, expressed on
platelets and endothelium, were detected in the serum. We address some of
the difficult diagnostic and management issues raised by this complex
patient and the possible immunopathological links between antibodies to
CD36, immune-mediated red cell destruction, thrombocytopenia and thrombotic
microangiopathic haemolytic anaemia.
相似文献
12.
We have previously reported that plasminogen activator inhibitor type-1 (PAI-1) expression in endothelial cells (ECs) can be modulated differently by smooth muscle cells depending on their origin. Human pulmonary artery smooth muscle cells (HPASMCs) strongly downregulated PAI-1 expression in ECs. Fibroblasts (FBs) are another cell type that could come in close contact with ECs. Therefore, it was the aim of this study to investigate whether FBs could also influence the fibrinolytic potential of ECs. As in the case of HPASMCs, PAI-1 antigen produced by human umbilical vein ECs (HUVECs) cocultured with human skin FBs (HSFBs) was significantly lower as compared with the sum of PAI-1 secreted by the respective cell types cultured separately. Not only HUVECs but also human skin microvascular ECs (HSMECs) responded in a dose-dependent way to serum-free conditioned media (CM) from HSFBs from one individual donor. Similar results were obtained when CM from HSFBs from four other individual donors were used. PAI-1 mRNA decreased in HUVECs incubated for 6 hours with HSFB-CM to 24% to 55% of control, depending on the preparation of HSFBs used. A significant PAI-1 downregulatory effect was only observed when CM from low-passage HSFBs (up to passage no. 5) was used, whereas no reduction in EC PAI-1 production was observed with CM obtained from HSFBs in passage no. 8. This PAI-1 downregulatory activity present in HSFB-CM was heat-labile and had a molecular mass of approximately 5 kD. When CM from HPASMCs was analyzed in the same way, an almost identical elution profile was found. In conclusion, our data showed that FBs can decrease the expression of PAI-1 in ECs. Such an effect could be operative during wound-healing and at other capillary sites where FBs could render ECs profibrinolytic, thereby facilitating processes requiring an increase in proteolytic activity such as EC migration and proliferation. 相似文献
13.
Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus 总被引:2,自引:2,他引:2
Acquired partial and complete deletions of chromosome 5 (5q-, -5) are common cytogenetic anomalies associated with myelodysplasia (MDS) and acute myeloid leukemia (AML). A critical region of consistent loss at 5q31.1 (in > 90% of cases) has led us and others to postulate the presence of a key negative regulator(s) of leukemogenesis. Although the interstitial deletion limits vary among patients, del(5) (q13q33) and del(5)(q13q35) constitute major subsets. Furthermore, it is not rare to encounter deletions, translocations, or paracentric inversions involving 5q11 to 5q13, which indicates inactivation or disruption of important gene(s) at that locus. In this report, we have localized a novel locus at 5q13.1 to a 2.0-Mb interval between the anonymous markers D5S672 and GATA-P1804. This locus resided within the region of loss in 12 of 27 patients with anomalies of chromosome 5; one of these cases had apparent retention of both alleles of all the telomeric loci. Fluorescence in situ hybridization (FISH) studies demonstrate that the AML cell line ML3 is disrupted at 5q13.1 by a translocation involving chromosome 3, with apparent retention of the entire chromosome 5 sequence. Our results suggest that this novel proximal locus encodes a critical gene that may be deleted or disrupted in a subset of MDS/AML patients with chromosome 5 anomalies. 相似文献
14.
A comparative analysis of enzymatic activities has been performed on 47 human continuous lymphoid lines: 22 tumors derived from Burkitt's lymphoma lines, 6 other lymphomatous long-term cultures, and 19 nonmalignant ties determined on the cell extracts. 4 showed no significant differences between the various lines. They included adenosine diphosphoribose incorporation, glucose-6-phosphate dehydrogenase, cyclic-AMP phosphodiesterase, and glutathione reductase. However, striking differences of activity were found for the enzyme, NAD(P) glycohydrolase (EC 3.2.2.6). Activity levels were, as a mean, four times higher in Burkitt's lymphoma-derived cell lines than in nonmalignant control lines, and the difference was highly significant (p less than 0.02). All Burkitt cell lines containing translocations of chromosome 8 with either chromosomes 2, 14 or 22 showed an increased activity. The specificity and significance of this possible enzymatic marker of Burkitt's lymphoma cells is discussed. 相似文献
15.
BO Motayo PA Akinduti FA Adeyakinu PO Okerentugba JC Nwanze CC Onoh HC Innocent-Adiele IO Okonko 《African health sciences》2013,13(4):1091-1097
Background
The increased reports of ESBL dissemination from various centres in south western, Nigeria and the recent emergence of carbapenem resistant bacteria prompted the conception of this study.Objectives
To demonstrate the relationship between high molecular weight plasmids and the expression of antibiotic multi-resistance including ESBL and carbapenemase.Methods
We investigated 97 isolates of selected organisms consisting of 67 E. coli and 30 Klebseilla spp for the presence of plasmids expressing ESBL including carbapenem-hydrolysing enzymes. Beta-lactamase was determined using acidometric method, while ESBL and carbapenemase activity was determined using the double-disk diffusion test as well as the Modified Hodge test (MHT). Plasmid profiles of ESBL and carbapenemase positive isolates were determined according to standard protocols.Results
An ESBL prevalence rate of 21.6% and carbapenem- resistance rate of 9.3% was recorded. Antibiotic susceptibility profile of ESBL isolates showed 100.0% resistance against Amoxicillin, Cotrimoxazole and Erythromycin. Moderate susceptibility was recorded against the Quinolone class of antibiotics; Meropenem remained the most active antibiotic against ESBL isolates with 62.5% against E. coli and 60% against K. pneumoniae. The plasmid profiles of our study isolates ranged from 11.8kbp to 35.5kbp.Conclusion
Due to the relationship between high molecular weight plasmids and multi-drug resistance, we hereby recommend regular molecular surveillance of this form in our study setting. 相似文献16.
Fiona?J?CharlsonEmail author Andrew?E?Moran Greg?Freedman Rosana?E?Norman Nicolas?JC?Stapelberg Amanda?J?Baxter Theo?Vos Harvey?A?Whiteford 《BMC medicine》2013,11(1):250
Background
Cardiovascular disease and mental health both hold enormous public health importance, both ranking highly in results of the recent Global Burden of Disease Study 2010 (GBD 2010). For the first time, the GBD 2010 has systematically and quantitatively assessed major depression as an independent risk factor for the development of ischemic heart disease (IHD) using comparative risk assessment methodology.Methods
A pooled relative risk (RR) was calculated from studies identified through a systematic review with strict inclusion criteria designed to provide evidence of independent risk factor status. Accepted case definitions of depression include diagnosis by a clinician or by non-clinician raters adhering to Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) classifications. We therefore refer to the exposure in this paper as major depression as opposed to the DSM-IV category of major depressive disorder (MDD). The population attributable fraction (PAF) was calculated using the pooled RR estimate. Attributable burden was calculated by multiplying the PAF by the underlying burden of IHD estimated as part of GBD 2010.Results
The pooled relative risk of developing IHD in those with major depression was 1.56 (95% CI 1.30 to 1.87). Globally there were almost 4 million estimated IHD disability-adjusted life years (DALYs), which can be attributed to major depression in 2010; 3.5 million years of life lost and 250,000 years of life lived with a disability. These findings highlight a previously underestimated mortality component of the burden of major depression. As a proportion of overall IHD burden, 2.95% (95% CI 1.48 to 4.46%) of IHD DALYs were estimated to be attributable to MDD in 2010. Eastern Europe and North Africa/Middle East demonstrate the highest proportion with Asia Pacific, high income representing the lowest.Conclusions
The present work comprises the most robust systematic review of its kind to date. The key finding that major depression may be responsible for approximately 3% of global IHD DALYs warrants assessment for depression in patients at high risk of developing IHD or at risk of a repeat IHD event.17.
JD Roberts JC Herkert J Rutberg SM Nikkel ACP Wiesfeld D Dooijes RM Gow JP van Tintelen MH Gollob 《Clinical genetics》2013,83(5):452-456
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited myocardial disease that predominantly affects the right ventricle and is associated with ventricular arrhythmias that may lead to sudden cardiac death. Mutations within at least seven separate genes have been identified to cause ARVC, however a genetic culprit remains elusive in approximately 50% of cases. Although negative genetic testing may be secondary to pathogenic mutations within undiscovered genes, an alternative explanation may be the presence of large deletions or duplications involving known genes. These large copy number variants may not be detected with standard clinical genetic testing which is presently limited to direct DNA sequencing. We describe two cases of ARVC possessing large deletions involving plakophilin‐2 (PKP2) identified with microarray analysis and/or multiplex ligation‐dependent probe amplification (MLPA) that would have been classified as genotype negative with standard clinical genetic testing. A deletion of the entire coding region of PKP2 excluding exon 1 was identified in patient 1 and his son. In patient 2, MLPA analysis of PKP2 revealed deletion of the entire gene with subsequent microarray analysis demonstrating a de novo 7.9 Mb deletion of chromosome 12p12.1p11.1. These findings support screening for large copy number variants in clinically suspected ARVC cases without clear disease causing mutations following initial sequencing analysis. 相似文献
18.
唐江琼摘译秦旭平审校 《南华大学学报(医学版)》2011,39(4):465-465
最近,美国哈佛大学医学部和麻省理工大学精神科学者发表文章强调抑郁症在心脏病患者中的发病率较高,约有20%~40%的心脏病人有严重抑郁障碍症状或经历抑郁性的症状。抑郁症状缓慢而持久, 相似文献
19.
20.
Tina Dorn Manon Ceelen Ming-Jan Tang Joyce L Browne Koos JC de Keijzer Marcel CA Buster Kees Das 《BMC public health》2011,11(1):190